Insilico Medicine is dedicated to develop high-performance AI platform for drug development to treat cancer and age-related diseases. Founded by Alex Zhavoronkov in 2014, Insilico Medicine is backed by investors that include Eight Roads Ventures, Juvenescence, Qiming Venture Partners, Sinovation Ventures, and WuXi AppTec and is headquartered in Rockville.